This collection of essays puts forward the arguments for and against relaxing the rules on direct to patient communication, with contributions from David Colin-Thome, Nicholas Bosanquet and Angela Coulter.
It tries to answer a number of questions including whether pharmaceutical companies should be allowed to communicate information about prescription only medicines directly to patients, could the supply of more information to patients help take the pressure off the NHS and who should be the gatekeeper of that information. It also looks at the example of the direct to consumer advertising of drugs in the US.
Download The Report: PDF